Research news

In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.

The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.

Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.

UCLH has begun recruiting participants to a trial looking at whether two antiviral drugs given to people who have tested positive for Covid-19 can stop the virus replicating.